EPSTEIN-BARR VIRUS INFECTION
Clinical trials for EPSTEIN-BARR VIRUS INFECTION explained in plain language.
Never miss a new study
Get alerted when new EPSTEIN-BARR VIRUS INFECTION trials appear
Sign up with your email to follow new studies for EPSTEIN-BARR VIRUS INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New vaccine trial aims to stop the virus that causes mono
⭐️ VACCINE ⭐️ Recruiting nowThis study tests two experimental vaccines designed to prevent Epstein-Barr virus (EBV) infection, which causes mono and is linked to certain cancers. About 750 healthy adults aged 18 to 29, both with and without prior EBV infection, will receive three doses of one or both vaccin…
Matched conditions: EPSTEIN-BARR VIRUS INFECTION
Phase: PHASE1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: ⭐️ VACCINE ⭐️
Last updated May 11, 2026 20:53 UTC
-
Engineered immune cells take on Post-Transplant virus
Disease control Recruiting nowThis study tests a new treatment for Epstein-Barr virus (EBV) infection that can occur after a stem cell transplant. The treatment uses specially engineered immune cells (EBV-TCR-T cells) to target and clear the virus. About 18 adults who have EBV in their blood despite standard …
Matched conditions: EPSTEIN-BARR VIRUS INFECTION
Phase: PHASE1, PHASE2 • Sponsor: Daihong Liu • Aim: Disease control
Last updated May 17, 2026 03:00 UTC